The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.
JPMorgan, Medtronic, Shopify and Perma-Pipe International are included in this Analyst Blog.
Medtronic (MDT) concluded the recent trading session at $88.26, signifying a +0.56% move from its prior day's close.
Company says the smallest knock can impact batteries by damaging internal electronics
Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.
Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) healthcare behemoth. Medtronic has increased its dividend for 47 consecutive years, with a 10-year dividend growth rate of 9.8%. Medtronic advanced its revenue from $20.3 billion in FY 2015 to $32.4 billion in FY 2024, a compound annual growth rate of 5.3%.
The best dividend stocks have a consistent history of paying and raising dividends in a wide range of economic landscapes. Medtronic is benefiting from its extensive portfolio of medical devices, and profits are growing.
Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year.